P071 Supporting extrapolation of indications for ABP 501, the first adalimumab biosimilar: focus on Crohn’s disease Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 25, 2019
has subject area
- 1103 Clinical Sciences (FoR)
- Gastroenterology & Hepatology (Science Metrix)
published in
- Journal of Crohn's and Colitis Journal